DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis
Clinical trial NCT05415722 · COMPLETED
Trial details
- NCT number
- NCT05415722
- Sponsor
- Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-28
- Primary completion
- 2023-07-10
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.